Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Testosterone replacement therapy for bone loss prevention in HIV-infected males
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Testosterone replacement therapy for bone loss prevention in HIV-infected males'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
HIV Patients
100%
Testosterone
100%
Testosterone Replacement Therapy
100%
Bone Loss Prevention
100%
Bone Loss
75%
HIV Infection
50%
Osteoporosis
50%
MEDLINE
25%
Sex Hormones
25%
Osteopenia
25%
Hormone Deficiency
25%
HIV-negative
25%
Endocrine Abnormalities
25%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Osteolysis
100%
Substitution Therapy
100%
Androgen Therapy
100%
Human Immunodeficiency Virus Infection
50%
Osteoporosis
50%
Sex Hormone
25%
Osteopenia
25%
Hormone Deficiency
25%
Nursing and Health Professions
Human Immunodeficiency Virus
100%
Substitution Therapy
100%
Androgen Therapy
100%
Human Immunodeficiency Virus Infection
50%
Osteopenia
25%
Sex Hormone
25%
Hormone Deficiency
25%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Replacement Therapy
100%
Human Immunodeficiency Virus Infection
50%
Sex Hormone
25%
Hormone Deficiency
25%
Osteopenia
25%
Veterinary Science and Veterinary Medicine
Osteolysis
100%
Reproductive Hormone
25%